Company intelligence / Profile preview

Labrida

Oslo, Norwaylabrida.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Labrida’s lead product, the chitosan-based BioClean® brush, has demonstrated significant reduction in pocket depth and inflammation around dental implants and teeth in clinical studies. It offers a gentle, biocompatible alternative for debridement with increased patient comfort compared to traditional methods. The device reduces aerosol generation during procedures—a benefit highlighted during the COVID era—and supports both surgical and non-surgical maintenance of oral health. The company has entered a major distribution partnership with Straumann Group to expand global reach.

Therapeutic areas
Infectious Diseases
Modalities
Device (chitosan-based dental brush)Biomaterial (chitosan)
Industry
Therapeutic Medical Devices
02

Drug pipeline

1 asset

Labrida BioClean

Commercial
Indications
Peri-implantitis, Periodontitis
03

Partnerships

Straumann Group (global distribution partner)

Beyond the preview

Go deeper on Labrida.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labrida.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call